High-dose radiation aims to control tough prostate cancer
NCT ID NCT02296229
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special type of radiation called stereotactic body radiotherapy (SBRT) for men with high-risk prostate cancer that hasn't spread. The treatment delivers a strong, focused dose of radiation to the tumor to kill cancer cells while sparing healthy tissue. Researchers are tracking how well it controls the cancer and how it affects patients' quality of life over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PROSTATE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Targeted radiation plus hormone therapy may slow Low-Volume prostate cancer spread
- Could a depression drug fight prostate cancer?
- New blood test aims to spot prostate cancer cells earlier
- Glow-in-the-Dark antibody could help surgeons spot prostate cancer
- Acupuncture needles aim to zap cancer brain fog
- Black raspberries under the microscope for prostate cancer prevention